The pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than one hundred million individuals, including more than two million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide and significantly increases the risk of hospitalization and death in COVID-19 patients. In this review, we discuss the prevalence, the pathophysiological mechanisms, and the outcomes of COVID-19 infection in people with diabetes. We propose a rationale for using drugs prescribed in patients with diabetes and some pragmatic clinical recommendations to deal with COVID-19 in this kind of patient.
Corrao S., Pinelli K., Vacca M., Raspanti M., Argano C. (2021). Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. FRONTIERS IN ENDOCRINOLOGY, 12 [10.3389/fendo.2021.609470].
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
Corrao S.Primo
;Pinelli K.;Argano C.Ultimo
2021-01-01
Abstract
The pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than one hundred million individuals, including more than two million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide and significantly increases the risk of hospitalization and death in COVID-19 patients. In this review, we discuss the prevalence, the pathophysiological mechanisms, and the outcomes of COVID-19 infection in people with diabetes. We propose a rationale for using drugs prescribed in patients with diabetes and some pragmatic clinical recommendations to deal with COVID-19 in this kind of patient.
| File | Dimensione | Formato | |
|---|---|---|---|
|
fendo-12-609470 (1).pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
330.12 kB
Formato
Adobe PDF
|
330.12 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
